Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guojun Hou

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cell Death Discovery|May 13, 2024
IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathwayDapeng Sun, Wen Li, Dongyang Ding, et al.
Immunohorizons|June 11, 2020
The MicroRNA <i>miR-22</i> Represses Th17 Cell Pathogenicity by Targeting PTEN-Regulated PathwaysLi Wang, Rong Qiu, Zhaoyang Zhang, et al.
Acta Biochimica Et Biophysica Sinica|March 19, 2019
Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer typesXinggang Guo, Zhiheng Wang, Jianing Zhang, et al.
Annals of Translational Medicine|July 16, 2021
Probabilistic ratiocination of hepatocellular carcinoma after resection: evaluation of expected to be promising approachesWei Dong, Xinggang Guo, Fuchen Liu, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 11, 2021
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosisTing Yu, Jiajian Yu, Lu Lu, et al.
Lupus Science & Medicine|April 10, 2024
Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLEXinyi Zhu, Yashuo Chen, Zhihua Yin, et al.
Acta Biochimica Et Biophysica Sinica|August 5, 2024
SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupusMengke Chen, Yutong Zhang, Weiwen Shi, et al.
Biology|August 26, 2023
Identification of Two Subsets of Subcompartment A1 Associated with High Transcriptional Activity and Frequent Loop ExtrusionZihang Yin, Shuang Cui, Song Xue, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2023
Three-Dimensional Chromosomal Landscape Revealing miR-146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR-Mediated Approach to Inhibit the Interferon PathwayXinyi Zhu, Yutong Zhang, Zihang Yin, et al.
Cell Death & Disease|May 9, 2022
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334Dapeng Sun, Xiaojie Gan, Lei Liu, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cell Death Discovery|May 13, 2024
IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathwayDapeng Sun, Wen Li, Dongyang Ding, et al.
Immunohorizons|June 11, 2020
The MicroRNA <i>miR-22</i> Represses Th17 Cell Pathogenicity by Targeting PTEN-Regulated PathwaysLi Wang, Rong Qiu, Zhaoyang Zhang, et al.
Acta Biochimica Et Biophysica Sinica|March 19, 2019
Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer typesXinggang Guo, Zhiheng Wang, Jianing Zhang, et al.
Annals of Translational Medicine|July 16, 2021
Probabilistic ratiocination of hepatocellular carcinoma after resection: evaluation of expected to be promising approachesWei Dong, Xinggang Guo, Fuchen Liu, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 11, 2021
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosisTing Yu, Jiajian Yu, Lu Lu, et al.
Lupus Science & Medicine|April 10, 2024
Novel potential lncRNA biomarker in B cells indicates essential pathogenic pathway activation in patients with SLEXinyi Zhu, Yashuo Chen, Zhihua Yin, et al.
Acta Biochimica Et Biophysica Sinica|August 5, 2024
SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupusMengke Chen, Yutong Zhang, Weiwen Shi, et al.
Biology|August 26, 2023
Identification of Two Subsets of Subcompartment A1 Associated with High Transcriptional Activity and Frequent Loop ExtrusionZihang Yin, Shuang Cui, Song Xue, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2023
Three-Dimensional Chromosomal Landscape Revealing miR-146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR-Mediated Approach to Inhibit the Interferon PathwayXinyi Zhu, Yutong Zhang, Zihang Yin, et al.
Cell Death & Disease|May 9, 2022
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334Dapeng Sun, Xiaojie Gan, Lei Liu, et al.
Pageof 5